Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

ARMP — Armata Pharmaceuticals, Inc. Dilution Risk Tracker

Track ARMP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARMP — Get alerts when the score changes →

As of October 13, 2026, Armata Pharmaceuticals, Inc. (ARMP) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Armata Pharmaceuticals, Inc. has a market capitalization of $134.97M, 37.18M shares outstanding, 45 institutional holders tracked. Stored dilution-related fields include 10.66M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊Float Risk—
⚠️ Warrant Exposure
70
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 35%
📜 Warrant Exercise model 40%
• Significant warrants: 29% of shares outstanding
• Elevated warrant risk score (70/100)
🔁 Convertible Conversion model 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
🔔 Track ARMP — Get forecast alerts →

Market Data

Market Cap$134.97M
Shares Outstanding37.18M
FloatN/A
Cash$23.95M
Debt$373.67M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding37.18MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$134.97MMarket data cache
Cash Runway6.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants10.66MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 245.9% shares (2026Q1 vs prior)
45 institutional holders · 4.34M shares
#1 Madison Asset Management, LLC 2.11M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 732.1K shares
#3 MILLENNIUM MANAGEMENT LLC 258.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest964.2K
Days to Cover6.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
xbrl XBRL CONVERTIBLE 2025-03-21
4 INSIDER TRANSACTION 2026-03-17
4 INSIDER TRANSACTION 2026-03-17
4 INSIDER TRANSACTION 2026-03-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ARMP Dilution Snapshot

Armata Pharmaceuticals, Inc. (ARMP) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ARMP's DilutionScore is currently 65/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 61/100 (High risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202665/100HIGH4 days
Sep 28 – Oct 09, 202661/100HIGH12 days
Aug 22 – Sep 27, 202656/100HIGH37 days
Jul 16 – Aug 21, 202665/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ARMP shares outstanding have increased 0.8% from 36.41M (Mar 2026) to 36.71M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202636.71M11.32M▲ 0.03%
May 08, 202636.70M11.32M▲ 0.38%
Apr 01, 202636.63M11.27M▲ 1.41%
Mar 27, 202636.63M11.12M▲ 0.83%
Mar 20, 202636.41M11.02M▼ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ARMP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ARMP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ARMP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ARMP
ARMP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.